Jonathan David Schwartz - 13 Sep 2022 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 13 Sep 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Sep 2022, 21:06:53 UTC
Prior SEC filing: 16 Aug 2022
Next SEC filing: 22 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Brian W. Adams, by Power of Attorney

Key filing fact

Jonathan David Schwartz filed Form 4 for Tabula Rasa HealthCare, Inc. on 15 Sep 2022.

Key facts

This page summarizes Jonathan David Schwartz's Form 4 filing for Tabula Rasa HealthCare, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2022, 21:06.

Change

Previous filing in this sequence was filed on 16 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRHC transaction

Common Stock

Award

Transaction value: $0
Shares: +52,747
Change %
Price: $0.000000
Shares after: 52,747
Date: 13 Sep 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Pursuant to the Tabula Rasa HealthCare, Inc. Non-Employee Director Compensation Policy (the "Policy"), the reporting person received an Initial Equity Award (as such term is defined in the Policy) of 52,747 shares of restricted stock of the issuer's common stock in connection with the reporting person's appointment to the issuer's Board of Directors.

Footnote F2

The restricted stock awards vest in three substantially equal annual installments on September 13, 2023, September 13, 2024, and September 13, 2025.